ArticleAnnals of biomedical engineering2026
A Novel Approach Combining Ultrasound-Induced Drug-Free Vasodilation and Photoacoustic Monitoring of Vascular Responses.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Pharmacological vasodilators are widely used to treat vascular disorders, but their systemic nature often leads to undesirable side effects. Moreover, conventional techniques for evaluating vascular responses-including ultrasound and wire myography-suffer from limited resolution or require invasive procedures. This study aimed to develop an integrated platform that overcomes both challenges simultaneously. A high-intensity focused ultrasound (HIFU) transducer was attached to the photoacoustic microscopy (PAM) system for integrated operation. Baseline images of murine ear and abdominal vessels were acquired prior to HIFU exposure. During the subsequent scan, HIFU was applied, while PAM captured the vascular response. As a result, HIFU application induced consistent and localized vasodilation in both the ear and abdominal vessels. PAM visualized the vascular changes, showing vessel diameter increases of approximately 9 to 21%. The integration of HIFU and PAM enables drug-free, localized modulation of vascular tone together with high-resolution in vivo vascular imaging. This integrated platform is intended as a preclinical research tool for studying localized vascular physiology and ultrasound-induced vascular responses without pharmacological intervention.
Indexed as
Identifiers
41973188What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.